These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7793454)

  • 1. Venlafaxine for adult ADHD.
    Wilens TE; Biederman J; Spencer TJ
    Am J Psychiatry; 1995 Jul; 152(7):1099-100. PubMed ID: 7793454
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of venlafaxine treatment for ADHD in a child.
    Pleak RR; Gormly LJ
    Am J Psychiatry; 1995 Jul; 152(7):1099. PubMed ID: 7793453
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
    Park P; Caballero J; Omidian H
    Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic properties of venlafaxine.
    Smith MN
    J Clin Psychiatry; 1997 Apr; 58(4):178-9. PubMed ID: 9164435
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder.
    Amiri S; Farhang S; Ghoreishizadeh MA; Malek A; Mohammadzadeh S
    Hum Psychopharmacol; 2012 Jan; 27(1):76-81. PubMed ID: 22252909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.
    Mukaddes NM; Abali O
    Psychiatry Clin Neurosci; 2004 Feb; 58(1):92-5. PubMed ID: 14678464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of venlafaxine in other psychiatric disorders.
    Ninan PT
    Depress Anxiety; 2000; 12 Suppl 1():90-4. PubMed ID: 11098421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of ADHD: children and adolescents.
    Findling RL; Dogin JW
    J Clin Psychiatry; 1998; 59 Suppl 7():42-9. PubMed ID: 9680052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine for treatment of obsessive-compulsive disorder.
    Ananth J; Burgoyne K; Smith M; Swartz R
    Am J Psychiatry; 1995 Dec; 152(12):1832. PubMed ID: 8526258
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of obsessive-compulsive disorder with venlafaxine.
    Grossman R; Hollander E
    Am J Psychiatry; 1996 Apr; 153(4):576-7. PubMed ID: 8599411
    [No Abstract]   [Full Text] [Related]  

  • 11. Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Findling RL; Greenhill LL; McNamara NK; Demeter CA; Kotler LA; O'Riordan MA; Myers C; Reed MD
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):433-45. PubMed ID: 17822339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine in obsessive-compulsive disorder.
    Yaryura-Tobias JA; Neziroglu FA
    Arch Gen Psychiatry; 1996 Jul; 53(7):653-4. PubMed ID: 8660133
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of familial erythromelalgia with venlafaxine.
    Firmin D; Roguedas AM; Greco M; Morvan C; Legoupil D; Fleuret C; Misery L
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):836-7. PubMed ID: 17567325
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination treatment with venlafaxine and bupropion.
    Kirsch MA; Louie AK
    Am J Psychiatry; 1999 Mar; 156(3):494. PubMed ID: 10080572
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.
    Levin FR; Bisaga A; Raby W; Aharonovich E; Rubin E; Mariani J; Brooks DJ; Garawi F; Nunes EV
    J Subst Abuse Treat; 2008 Jan; 34(1):80-9. PubMed ID: 17574796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine versus fluoxetine.
    Paton C
    J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
    [No Abstract]   [Full Text] [Related]  

  • 17. Venlafaxine and fibromyalgia.
    Dryson E
    N Z Med J; 2000 Mar; 113(1105):87. PubMed ID: 10855592
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic fatigue syndrome with venlafaxine.
    Goodnick PJ
    Am J Psychiatry; 1996 Feb; 153(2):294. PubMed ID: 8561218
    [No Abstract]   [Full Text] [Related]  

  • 20. Venlafaxine XR and chronic pelvic pain syndrome.
    Karp JF
    J Clin Psychiatry; 2004 Jun; 65(6):880-1. PubMed ID: 15291672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.